Bringing Dermatology Solutions to Market
Our Passion is to bring dermatology solutions to market which help to relieve children and adults suffering from mild to medium Eczema (Atopic Dermatitis).
Strategic Partnership & Investment InquiriesOur Ambition
A focused approach to bringing innovative dermatology solutions from concept to clinic.
Partner with IP Inventors
Collaborate with leading intellectual property innovators in dermatological science to develop breakthrough treatments.
Appoint Best In Class Team
Assemble world-class advisors and professionals in dermatology, clinical development, and regulatory affairs.
Cost Effective Development Partnerships
Leverage strategic partnerships to advance clinical programs efficiently while maintaining the highest quality standards.
Attractive Investment Vehicle
Provide investors with a compelling opportunity in the growing dermatology market focused on unmet medical needs.
The Untapped Potential of Fexofenadine
Our proprietary topical Fexofenadine formulation targets multiple pathways involved in Atopic Dermatitis, offering a novel multi-action approach to treating eczema.
Learn more about our science →Latest News
Celfex AB to engage Noah Therapeutics for Phase 2 Clinical Trial
Celfex AB announces engagement with Noah Therapeutics to conduct a Phase 2 clinical trial for its topical Fexofenadine formulation.
Celfex AB enters sub-license agreement with MHG
Celfex AB has entered into a sub-license agreement with MHG Management GmbH for the development of topical Fexofenadine.
Strategic Partnership & Investment Inquiries
We are seeking strategic partners and investors who share our vision of bringing innovative dermatology treatments to patients worldwide.
Get In Touch